Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,929
Closed -$94.8K 256
2025
Q1
$94.8K Hold
10,929
0.01% 236
2024
Q4
$133K Buy
+10,929
New +$153K 0.01% 246
2023
Q3
Sell
-9,785
Closed -$213K 105
2023
Q2
$213K Buy
+9,785
New +$177K 0.04% 94
2022
Q1
Sell
-6,486
Closed -$295K 99
2021
Q4
$295K Hold
6,486
0.05% 82
2021
Q3
$282K Hold
6,486
0.05% 83
2021
Q2
$299K Hold
6,486
0.05% 80
2021
Q1
$288K Hold
6,486
0.06% 79
2020
Q4
$257K Sell
6,486
-34
-0.5% -$1.26K 0.05% 86
2020
Q3
$255K Hold
6,520
0.06% 74
2020
Q2
$253K Hold
6,520
0.09% 66
2020
Q1
$218K Hold
6,520
0.1% 56
2019
Q4
$213K Hold
6,520
0.08% 66
2019
Q3
$222K Buy
+6,520
New +$226K 0.09% 61

Other funds holding NEOG

Hardy Reed's NEOG Position: Q2 2025 in Review

Hardy Reed sold out of Neogen (NEOG) in Q2 2025, closing a stake of 10,929 shares — an estimated $94.8K sold.

Hardy Reed first reported a position in NEOG in Q3 2019 and held it in 13 quarters. The position peaked at $299K in Q2 2021. 317 funds tracked by Wall St. Rank hold NEOG as of Q2 2025.

  • Hardy Reed reported no remaining Neogen position as of Q2 2025 after selling out during the quarter.
  • Hardy Reed sold 10,929 Neogen shares in Q2 2025, an estimated $94.8K.
  • Hardy Reed first reported a position in Neogen in Q3 2019 and held it in 13 quarters.
  • Hardy Reed's Neogen position peaked at $299K in Q2 2021.
  • 317 funds tracked by Wall St. Rank held Neogen as of Q2 2025.

Based on Hardy Reed's 13F filing for Q2 2025, filed 23 Jul 2025.